Delivery Order SPE2DE24DA011-SPE2D626F37P5
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,509.51 to Arthrex Inc. for an implant system secondary fixation bioswalk device (4.75x19.1) with a completion date of November 28, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and represents a task order issued under Arthrex's existing Indefinite Delivery Contract SPE2DE24D0020, a comprehensive master agreement valued at $471 million effective through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,257.22 fixed-price delivery order on September 16, 2025, for an implant system secondary fixation bioscaffold measuring 4.75x19.1 millimeters. This delivery order, with an ultimate completion date of September 19, 2025, was issued under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Medical Supply Chain, a defense-affiliated federal agency. The...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,932.74 to Arthrex Inc. for a Proximal Tenodesis Implant System, effective September 29, 2025, with an ultimate completion date of October 2, 2025. This fixed-price contract with economic price adjustment clauses was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The contractor, headquartered in Naples,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,983.10 to Arthrex Inc. for an Implant System, SutureLoc, with an ultimate completion date of December 18, 2025. This fixed-price delivery order with economic price adjustment was issued without set-aside designation to the Naples, Florida-based orthopedic medical device manufacturer. The order falls under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Medical Supply Chain, a $471...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,397.84 to Arthrex Inc. for a Proximal Tenodesis Implant System, with a completion deadline of December 18, 2025. This fixed-price delivery order with economic price adjustment was issued without set-aside designation to the Naples, Florida-based orthopedic medical device manufacturer. The award represents a task order issued under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the...
- The Department of Defense's Medical Supply Chain awarded Arthrex Inc. a $5,110.38 fixed-price delivery order for a Quadlink Implant System, 9mm, with an ultimate completion date of December 11, 2025. This delivery order was issued without a set-aside designation, reflecting Arthrex's competitive position as a leading supplier of minimally invasive orthopedic medical technologies to federal healthcare systems. The work will be performed in Naples, Florida, where Arthrex maintains its headquarters...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a fixed-price delivery order valued at $8,230.08 with an ultimate completion date of December 1, 2025, by the Defense Logistics Agency's Medical Supply Chain. The award, issued without set-aside designation on November 25, 2025, is for an implant system secondary fixation bioswalk measuring 4.75x19.1 millimeters. This delivery order falls under Arthrex's larger single-award Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded Arthrex Inc. a delivery order valued at $2,449.85 on December 1, 2025, for an implant tightening product (IMPLANT TIGHTRP BTB 1S) with an ultimate completion date of December 15, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation and will be performed in Naples, Florida, where Arthrex maintains its headquarters. The delivery order falls under Arthrex's comprehensive Indefinite...
- The Department of Defense's Medical Supply Chain has awarded a $12,532.55 fixed-price delivery order to Arthrex Inc. for an Implant System, SutureLoc. This delivery order, issued on December 9, 2025, with an ultimate completion date of December 12, 2025, represents a task order under Arthrex's larger single-award Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and effective through September 1, 2029. The award carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $4,222.02 for an Implant System, Fibertak Button from the Defense Logistics Agency's Medical Supply Chain on June 2, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of June 13, 2025, and was awarded without set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D626F37P5Delivery Order
The Defense Logistics Agency's Medical Supply Chain has awarded a $1,072.35 fixed-price delivery order to Arthrex Inc. for an implant system secondary fixation bioswalk measuring 4.75x19.1, with an ultimate completion date of December 23, 2025. This delivery order, issued without set-aside designation, represents a task order placed under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Medical Supply Chain, valued at $471 million and running through September 1, 2029. Arthrex, a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies and implants, serves as the prime contractor with no identified subcontractors on this task order. The delivery order supports the federal government's orthopedic healthcare requirements across Department of Defense and Department of Veterans Affairs facilities nationwide. Arthrex's comprehensive IDC portfolio includes surgical implants, arthroscopic instruments, joint replacement technologies, and specialized biological products serving foot and ankle, shoulder, knee, hand, and general orthopedic surgical specialties. The company has demonstrated substantial federal contracting capability and maintains a strong competitive position reflected in its sole-source procurement awards and direct relationships with federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/16/25 |